Viactiv recognized for excellence in women's health products.

  • Viactiv celebrated for women's health initiatives
  • Recognized for commitment to quality health products
  • Award reflects consumer trust and brand excellence

Viactiv has been honored with the 2026 Women’s Choice Award, a recognition that underscores its dedication to women’s health. This accolade reflects the brand's commitment to producing quality health products that cater specifically to women's needs. The Women’s Choice Award is given based on rigorous evaluation criteria that highlight consumer trust and satisfaction.

The Women’s Choice Award evaluates brands based on feedback from women consumers across the country, ensuring that the products meet a standard of excellence. Viactiv’s receipt of this honor emphasizes its role in the health and wellness sector, particularly in delivering beneficial supplements for women. This award not only marks a significant milestone for the company but also reinforces its mission to improve women's health.

As part of the recognition process, Viactiv underwent thorough consumer research and analysis, confirming its valued status among women in the marketplace. Additionally, the award serves to inform consumers of brands committed to offering products that positively impact women's health.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation

Innovative automation enhances cancer research and immunological studies. AI-powered tools improve research…

Pharmacelera Raises $6M to Expand in US and Enhance Drug Discovery Platform

Funding will support growth and technological advancements in drug discovery. Pharmacelera has…

NUNM Receives $1.5 Million Gift to Support Campus Expansion and Future Integrative Medicine Center

Major donation aims to enhance educational opportunities at NUNM. NUNM receives a…

WuXi Biologics and Vertex Enter Research Agreement for T-Cell Engager

Collaboration focuses on advancing T-cell engager therapies for cancer treatment WuXi Biologics…